What is Canakinumab?

Category: Prescription Drugs

Most popular types: Ilaris


Canakinumab is an interleukin-1 beta-blocker. It is used to decrease inflammation in such conditions as Cryopyrin-Associated Periodic Syndromes (CAPS) and Active Systemic Juvenile Idiopathic Arthritis.

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations Percentage
Severe 0
Moderate 0
Mild 0
None 1

Commonly reported side effects and conditions associated with Canakinumab

Side effect Patients Percentage


Based on patients currently taking Canakinumab

Dosage Patients Percentage
22500 mg monthly 1


Currently taking Canakinumab

Duration Patients Percentage
1 - 2 years 1
Adherence Evaluations Percentage
Always 1
Usually 0
Sometimes 0
Never taken as prescribed 0
Burden Evaluations Percentage
Very hard to take 0
Somewhat hard to take 0
A little hard to take 0
Not at all hard to take 1
Cost per month
Cost per month Evaluations Percentage
$200+ 0
$100-199 0
$50-99 0
$25-49 0
< $25 1
Not specified 0

What people switch to and from

Patients started taking Canakinumab after stopping:

Treatment Patients Percentage
Anakinra (Kineret) 1
Colchicine (Colcrys) 1
Last updated:
There are no evaluations for Canakinumab.